Charles River Laboratories (CRL)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 575,538 | 616,605 | 472,855 | 446,112 | 302,042 |
| Revenue | US$ in thousands | 4,082,940 | 4,098,090 | 3,457,220 | 2,939,570 | 2,582,040 |
| Pretax margin | 14.10% | 15.05% | 13.68% | 15.18% | 11.70% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $575,538K ÷ $4,082,940K
= 14.10%
Charles River Laboratories pretax margin has exhibited some variability over the past five years, ranging from 11.70% in 2019 to 15.05% in 2022. The company's pretax margin was 14.10% in 2023, showing a slight decrease compared to the previous year.
The pretax margin indicates the percentage of each dollar of revenue that results in pre-tax profit. A higher pretax margin suggests that the company is more efficient in generating profits from its operations. Therefore, a declining trend in the pretax margin may raise concerns about the company's profitability efficiency.
Further analysis would be required to understand the factors contributing to the fluctuation in Charles River Laboratories' pretax margin over the years, such as changes in costs, revenues, or operating efficiency. Monitoring this metric over time can provide valuable insights into the company's financial health and operational performance.
Peer comparison
Dec 31, 2023